98 related articles for article (PubMed ID: 36481091)
1. Qualitative analysis of telephonic comprehensive medication review content and delivery.
Dhatt H; Vaffis S; Le D; Axon DR; Campbell PJ; Black H; Kolobova I; Nelson ML; Warholak T
J Am Pharm Assoc (2003); 2023; 63(2):555-565. PubMed ID: 36481091
[TBL] [Abstract][Full Text] [Related]
2. Key informant perspectives about telephonic comprehensive medication review services in the United States.
Anderson EJ; Dhatt H; Vaffis S; Nelson ML; Warholak T; Campbell PJ; Black H; Kolobova I; Axon DR
J Am Pharm Assoc (2003); 2022; 62(3):817-825.e1. PubMed ID: 35067476
[TBL] [Abstract][Full Text] [Related]
3. A checklist for a consistent, comprehensive medication review.
Vaffis S; Dhatt H; Anderson E; Le D; Campbell PJ; Nelson M; Black H; Kolobova I; Axon DR; Warholak T
J Am Pharm Assoc (2003); 2023; 63(5):1504-1507.e1. PubMed ID: 37394060
[TBL] [Abstract][Full Text] [Related]
4. Trends in telephonic comprehensive medication review in the United States from 2000 to present: a scoping literature review.
Vaffis S; Dhatt H; Anderson EJ; Nelson M; Campbell P; Black H; Kolobova I; Warholak T
J Am Pharm Assoc (2003); 2022; 62(2):406-412.e1. PubMed ID: 35067477
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive medication review service by embedded pharmacists in primary care: Innovations and impact.
Yoo A; Fennelly JE; Renauer MM; Coe AB; Choe HM; Marshall VD; Parsons D; Farris KB
J Am Pharm Assoc (2003); 2022; 62(2):580-587.e1. PubMed ID: 34696978
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
9. Social needs of dual-enrolled Medicare-Medicaid patients with medication nonadherence in a telehealth medication therapy management program.
Almodóvar AS; Ross E; Nahata MC; Bingham JM
J Manag Care Spec Pharm; 2023 Feb; 29(2):210-215. PubMed ID: 36705284
[No Abstract] [Full Text] [Related]
10. Impact of telephonic comprehensive medication reviews on patient outcomes.
DeZeeuw EA; Coleman AM; Nahata MC
Am J Manag Care; 2018 Feb; 24(2):e54-e58. PubMed ID: 29461851
[TBL] [Abstract][Full Text] [Related]
11. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
[TBL] [Abstract][Full Text] [Related]
12. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies identified with the use of prescription claims and diagnostic billing data following a comprehensive medication review.
Roane TE; Patel V; Hardin H; Knoblich M
J Manag Care Pharm; 2014 Feb; 20(2):165-73. PubMed ID: 24456318
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
[TBL] [Abstract][Full Text] [Related]
15. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Medication Review Completion in Medically Underserved Areas and Populations.
Le LD; Paulk IR; Axon DR; Bingham JM
J Health Care Poor Underserved; 2021; 32(3):1301-1311. PubMed ID: 34421032
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive medication reviews by ward-based pharmacists in Swedish hospitals: What does the patient have to say?
Kempen TGH; Kälvemark A; Gillespie U; Stewart D
J Eval Clin Pract; 2020 Feb; 26(1):149-157. PubMed ID: 30834647
[TBL] [Abstract][Full Text] [Related]
18. Community pharmacists' and residents' decision making and unmet information needs when completing comprehensive medication reviews.
McPherson KL; Adeoye-Olatunde OA; Osborne JM; Doucette WR; Gernant SA; Jaynes H; Phansalkar S; Russ-Jara AL; Snyder ME
J Am Pharm Assoc (2003); 2020; 60(3S):S41-S50.e2. PubMed ID: 31987810
[TBL] [Abstract][Full Text] [Related]
19. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
[TBL] [Abstract][Full Text] [Related]
20. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
Murugappan MN; Seifert RD; Farley JF
J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
